2. Research
  3. Clinical Research
  4. Clinical Research Section
  5. Current Grant Support for Clinical Research

Current Grant Support for Clinical Research

  1. “The Major Extremity Trauma and Rehabilitation Research Consortium | PRECISE, EMSBIND, CBPT, AlterG”

$726,104 2017 – Current

Federal Support, METRC

PI: Warner, Stephen

  1. “The Mobility Toolkit: Electronically Augmented Assessment of Functional Recovery Following Lower-Extremity Trauma”

PI: Warner, Stephen

Federal Support, METRC

$72,125 2018 – Current

  1. “TOBRA – Novel Topical Antibiotic Therapy to Reduce Infection after Operative Treatment of Fractures at High Risk of Infection: A Multicenter Randomized, Controlled Trial”

PI: Warner, Stephen

Federal Support, METRC

$14,621 2020 – Current

  1. “SEXTANT: Title Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures”

PI: Warner, Stephen

Federal Support, METRC

$7,076 2021 – Current

  1. “Effect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures: A Pragmatic, Randomized Controlled Trial”

PI: Warner, Stephen

Federal Support, METRC

$80,217 2020 – Current

  1. “Subacromial Bursa Implantation After Rotator Cuff Repair – A Randomized Controlled Trial”

PI: Gregory, James

Industry Support, Arthrex Inc.

$69,420 2021 – Current

  1. “Proximal Humerus Fixation with the Conventus CAGETM PH Device: A Post-Approval Observational Data Collection Study, A Single Center Study, Memorial Hermann”

PI: Gregory, James

Industry Support, Conventus Orthopaedics, Inc.

$96,335 2017 – Current

  1. “OXINIUM DH Total Hip Replacement System in Subjects with Non-Inflammatory Arthritis”

PI: Mathis, Kenneth

Industry Support, Smith & Nephew Inc.

$45,013 2019 – Current

  1. “IlluminOss(R) Device Global Registry – A Prospective, Post-Market, Multi-Center Evaluation of the Clinical Outcomes of the IlluminOss Device”

PI: Harvin, William

Industry Support, IlluminOss Medical Inc.

$27,953 2022 – Current

  1. “CIVO(R) Microdose Injections of Anti-Cancer Therapies”

PI: Conrad, Ernest

Industry Support, Presage Biosciences, Inc.

$48,815 2021 – Current

  1. “Evaluation of a Steady State Visual Evoked Potentials (SSVEP) in mild Traumatic Brain Injury (mTBI)”

PI: Ott, Summer

Industry Support, HeadsafeIP Pty Ltd

$37,635 2021 – Current

  1. “Tornier PERFORM Stemless Reverse IDE Study”

PI: Gregory, James

Industry Support, Stryker Orthopaedics

$17,557 2022 – Current

  1. “A Phase 1b Open-Label, Dose-Escalating Study to Evaluate the Safety and Tolerability of PLG0206 in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Occurring After Total Knee Arthroplasty (TKA)”

PI: Rodriguez-Quintana, David

Industry Support, Peptilogics Inc.

$28,921 2022 – Current

  1. “Double Blinded Prospective Pilot Study to Determine the Safety and Effectiveness of a Connective Tissue Allograft (Active Matrix¿) vs. Standard of Care in Adhesive Capsulitis of the Shoulder”

PI: Berkman, Eric

Industry Support, Skye Biologics Holdings, LLC

$39,534 2022 – Current

  1. “Multicenter, Prospective Post-Market Clinical Follow-Up Study of the G7(R) Freedom Constrained Vivacit-E(R) Liner”

PI: Rodriguez-Quintana, David

Industry Support, Zimmer Biomet Inc.

$11,011 2023 – Current

  1. “Sacral Fracture Fusion/Fixation for Rapid Rehabilitation”

PI: Prasarn, Mark

Industry Support, SI-BONE, Inc.

$9,711 2023 – Closing Early

  1. “A Multi-Centre Study in Patients Undergoing Total Knee Replacement with Smith+Nephew Porous Total Knee Arthroplasty (TKA) System”

PI: Mathis, Kenneth

Industry Support, Smith & Nephew Inc.

10,070 2023 – Current